Baader Bank Aktiengesellschaft’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.29M Sell
2,539
-1,340
-35% -$1.36M 0.18% 107
2025
Q4
$4.09M Sell
3,879
-428
-10% -$409K 0.28% 73
2025
Q3
$2.85M Buy
4,307
+464
+12% +$345K 0.19% 94
2025
Q2
$2.94M Sell
3,843
-1,448
-27% -$1.13M 0.21% 96
2025
Q1
$4.24M Buy
5,291
+1,001
+23% +$833K 0.32% 97
2024
Q4
$3.31M Sell
4,290
-271
-6% -$224K 0.22% 104
2024
Q3
$3.89M Sell
4,561
-3,427
-43% -$3.08M 0.23% 101
2024
Q2
$7.1M Buy
7,988
+3,917
+96% +$3.13M 0.45% 76
2024
Q1
$3.17M Buy
4,071
+3,031
+291% +$2.16M 0.23% 90
2023
Q4
$600K Sell
1,040
-716
-41% -$418K 0.04% 195
2023
Q3
$917K Buy
1,756
+977
+125% +$503K 0.06% 156
2023
Q2
$284K Buy
+779
New +$327K 0.01% 291
2023
Q1
Sell
-1,700
Closed -$622K 435
2022
Q4
$622K Sell
1,700
-2,740
-62% -$971K 0.03% 243
2022
Q3
$1.44M Buy
4,440
+1,354
+44% +$429K 0.09% 176
2022
Q2
$1M Buy
+3,086
New +$926K 0.08% 189

Other funds holding LLY

Baader Bank Aktiengesellschaft's LLY Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft reduced its Eli Lilly (LLY) stake by 35% in Q1 2026, selling an estimated $1.36M and leaving 2,539 shares worth $2.29M. The position accounts for 0.18% of the portfolio, ranked #107.

Baader Bank Aktiengesellschaft first reported a position in LLY in Q2 2022 and has held it in 15 quarters since. The position peaked at $7.1M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Baader Bank Aktiengesellschaft held 2,539 shares of Eli Lilly worth $2.29M as of Q1 2026.
  • Baader Bank Aktiengesellschaft sold 1,340 Eli Lilly shares in Q1 2026, an estimated $1.36M.
  • Eli Lilly made up 0.18% of Baader Bank Aktiengesellschaft's portfolio in Q1 2026, its #107 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Eli Lilly in Q2 2022 and has held it in 15 quarters since.
  • Baader Bank Aktiengesellschaft's Eli Lilly position peaked at $7.1M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.